Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

FSD Pharma Inc. (C:HUGE)

Business Focus: Alternative Medicine

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for HUGE within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 11, 2021 08:40 ET
FSD Pharma Announces US$20M At-The-Market Offering
FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that it has entered into an Equity Distribution Agreement dated February 11, 2021 (the "Sales Agreement") with A.G.P./Alliance Global Partners (the "Sales Agent"). Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company (the "Class B Shares"). Sales of Class B Shares will be made through "at-the-market distributions" as
Read full article
Jan 26, 2021 19:30 ET
FSD Provides Corporate Update
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
239.42
14.28
16.62
Price to Book - most recent quarter
0.90
3.54
4.81
Price to Cash Flow per share - TTM
--
15.83
16.82
Price to Free Cash Flow per share - TTM
--
41.28
32.42
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Feb 15, 202164,13026,751
Jan 31, 202137,37911,797
Jan 15, 202125,582-14,275
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

FSD Pharma Inc is a Canada-based company engaged in the cultivation of cannabis. The Company through its wholly owned subsidiary, FV Pharma, operates as an authorized licensed producer of cannabis for medical purposes (ACMPR). In addition, the Company also owns stakes in Canara, which specializes in indoor cultivation.

See business summary

 

Twitter

Search (past week) for $HUGE.CA

  • No tweets found